News
Filter
-
LifeArc-founded RQ Bio secures £85.5 million to advance long-acting antibody for influenza prevention
-
New boost for personalised rare disease treatments as the Rare Therapies Launch Pad becomes part of LifeArc
-
World-first gene therapy to target devastating rare immune disorder
-
LifeArc announces partnership with Elpida Therapeutics to accelerate gene therapies for ultra-rare diseases in children
-
LifeArc Translational Science Summit 2026: Charting new paths for rare disease
-
From curiosity to career: LifeArc placement students share their stories for British Science Week
-
First projects backed by C-Further consortium to develop better treatments for children with cancer
-
International Women’s Day 2026: Stories of support, confidence and paying it forward
-
First‑of‑its‑kind UK data initiative to boost early diagnosis and deliver better treatments for children with rare diseases
-
The future of brain health: Early detection, equity and systematic change
-
Could a nasal insulin spray improve the lives of children and young people living with a rare condition?
-
Scientists test whether a finger prick blood test could be used to help diagnose Alzheimer’s disease before symptoms begin
